IL276563B2 - Factor XIa or kallikrein inhibitor compounds, preparations containing them and uses thereof - Google Patents

Factor XIa or kallikrein inhibitor compounds, preparations containing them and uses thereof

Info

Publication number
IL276563B2
IL276563B2 IL276563A IL27656320A IL276563B2 IL 276563 B2 IL276563 B2 IL 276563B2 IL 276563 A IL276563 A IL 276563A IL 27656320 A IL27656320 A IL 27656320A IL 276563 B2 IL276563 B2 IL 276563B2
Authority
IL
Israel
Prior art keywords
compound
nonhn
onnn
formula
subject
Prior art date
Application number
IL276563A
Other languages
English (en)
Hebrew (he)
Other versions
IL276563B1 (en
IL276563A (en
Original Assignee
Exithera Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exithera Pharmaceuticals Inc filed Critical Exithera Pharmaceuticals Inc
Publication of IL276563A publication Critical patent/IL276563A/en
Publication of IL276563B1 publication Critical patent/IL276563B1/en
Publication of IL276563B2 publication Critical patent/IL276563B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL276563A 2018-02-07 2019-02-04 Factor XIa or kallikrein inhibitor compounds, preparations containing them and uses thereof IL276563B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862627435P 2018-02-07 2018-02-07
PCT/US2019/016503 WO2019156929A1 (en) 2018-02-07 2019-02-04 Therapeutic compounds and compositions

Publications (3)

Publication Number Publication Date
IL276563A IL276563A (en) 2020-09-30
IL276563B1 IL276563B1 (en) 2026-01-01
IL276563B2 true IL276563B2 (en) 2026-05-01

Family

ID=67548561

Family Applications (2)

Application Number Title Priority Date Filing Date
IL276563A IL276563B2 (en) 2018-02-07 2019-02-04 Factor XIa or kallikrein inhibitor compounds, preparations containing them and uses thereof
IL325484A IL325484A (en) 2018-02-07 2025-12-21 Factor Xia or Kallikrein Inhibitor Compounds, Compositions Containing Them and Uses Thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL325484A IL325484A (en) 2018-02-07 2025-12-21 Factor Xia or Kallikrein Inhibitor Compounds, Compositions Containing Them and Uses Thereof

Country Status (10)

Country Link
US (2) US11691962B2 (cg-RX-API-DMAC7.html)
EP (1) EP3749662A4 (cg-RX-API-DMAC7.html)
JP (2) JP7397797B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200118088A (cg-RX-API-DMAC7.html)
CN (1) CN111902404A (cg-RX-API-DMAC7.html)
AU (1) AU2019217366B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020016123A2 (cg-RX-API-DMAC7.html)
CA (1) CA3089970A1 (cg-RX-API-DMAC7.html)
IL (2) IL276563B2 (cg-RX-API-DMAC7.html)
WO (1) WO2019156929A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9499532B2 (en) 2014-02-07 2016-11-22 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
WO2019156929A1 (en) 2018-02-07 2019-08-15 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108039A2 (en) * 2005-04-04 2006-10-12 Daiamed, Inc. Substituted azetidinones
US20150225389A1 (en) * 2014-02-07 2015-08-13 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
WO2018118705A1 (en) * 2016-12-23 2018-06-28 Exithera Pharmaceuticals, Inc. Therapeutic compounds and compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595532A (en) 1983-02-02 1986-06-17 University Of Notre Dame Du Lac N-(substituted-methyl)-azetidin-2-ones
WO1999037668A1 (de) 1998-01-26 1999-07-29 Basf Aktiengesellschaft Thrombininhibitoren
US6335324B1 (en) 1998-06-25 2002-01-01 Bristol-Myers Squibb Co. Beta lactam compounds and their use as inhibitors of tryptase
CA2336003A1 (en) 1998-06-25 1999-12-29 Zhongmin Xu Amidino and guanidino azetidinone tryptase inhibitors
WO2000005204A1 (en) 1998-07-23 2000-02-03 Shionogi & Co., Ltd. MONOCYCLIC β-LACTAM COMPOUNDS AND CHYMASE INHIBITORS CONTAINING THE SAME
KR20060120601A (ko) 2003-08-22 2006-11-27 데이진 화-마 가부시키가이샤 키마제 저해제를 유효 성분으로서 함유하는 약제
TW200745084A (en) 2006-03-08 2007-12-16 Astrazeneca Ab Novel compounds
WO2010147791A1 (en) * 2009-06-16 2010-12-23 Boehringer Ingelheim International Gmbh Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
JP5844287B2 (ja) 2010-02-11 2016-01-13 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 第xia因子阻害剤としてのマクロ環
LT2766346T (lt) 2011-10-14 2017-06-12 Bristol-Myers Squibb Company Pakeistieji tetrahidroizochinolino junginiai, kaip faktoriaus xia inhibitoriai
SG11201406142XA (en) 2012-03-27 2014-10-30 Univ Duke Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
WO2019156929A1 (en) 2018-02-07 2019-08-15 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
CA3117549A1 (en) 2018-10-30 2020-05-07 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
CA3117470A1 (en) 2018-10-30 2020-05-07 Exithera Pharmaceuticals, Inc. Therapeutic compounds and compositions
KR20210119432A (ko) 2019-01-29 2021-10-05 엑시테라 파마슈티컬스 인코퍼레이티드 치료 화합물 및 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108039A2 (en) * 2005-04-04 2006-10-12 Daiamed, Inc. Substituted azetidinones
US20150225389A1 (en) * 2014-02-07 2015-08-13 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
WO2018118705A1 (en) * 2016-12-23 2018-06-28 Exithera Pharmaceuticals, Inc. Therapeutic compounds and compositions

Also Published As

Publication number Publication date
AU2019217366A1 (en) 2020-08-20
EP3749662A4 (en) 2021-07-14
IL276563B1 (en) 2026-01-01
IL325484A (en) 2026-02-01
US12152014B2 (en) 2024-11-26
US20210188812A1 (en) 2021-06-24
RU2020129237A (ru) 2022-03-09
AU2019217366B2 (en) 2024-07-11
JP2021512894A (ja) 2021-05-20
CA3089970A1 (en) 2019-08-15
KR20200118088A (ko) 2020-10-14
JP7397797B2 (ja) 2023-12-13
JP2024023490A (ja) 2024-02-21
EP3749662A1 (en) 2020-12-16
IL276563A (en) 2020-09-30
CN111902404A (zh) 2020-11-06
WO2019156929A1 (en) 2019-08-15
US20240059670A1 (en) 2024-02-22
BR112020016123A2 (pt) 2021-02-23
US11691962B2 (en) 2023-07-04

Similar Documents

Publication Publication Date Title
IL276082B1 (en) DNA-pk inhibitor compounds, preparations containing them and their uses
IL276080A (en) DNA-pk suppressor compounds, UTP-containing preparations and their uses
IL274006A (en) Compounds that suppress factor Xia or kallikrein and preparations containing them
IL285302A (en) Compounds, preparations and methods
IL285177A (en) compounds and their use
IL274297A (en) Pyrazolo-piperidine-converted indole-2-carboxamides, preparations containing them and their uses
IL285167A (en) Compounds that suppress factor xia and kallikrein, preparations containing them and their uses
IL286497A (en) compounds and their use
PT3676297T (pt) Compostos, composições e métodos
IL278758A (en) VMAT2 inhibitory compounds, compositions and methods related thereto
PL3837256T3 (pl) Związki i kompozycje mocznika jako inhibitory smarca2/brm-atpazy
IL325484A (en) Factor Xia or Kallikrein Inhibitor Compounds, Compositions Containing Them and Uses Thereof
ZA202109737B (en) Compound used as kinase inhibitor and application thereof
IL282766A (en) Compounds that suppress factor XIa, kallikrein, methods for their production and their uses
IL288024A (en) Methods and preparations for the prevention of type 1 diabetes
IL262020B (en) Grisiofulvin compound, preparations containing it and its uses
IL253705B (en) Converted triazoles, preparations containing them and their uses
IL291499A (en) Azaquinoline compounds and their uses
IL298860B1 (en) GCN 2 inhibitor compounds, compositions containing them and uses thereof
TN2018000057A1 (en) Compounds useful for inhibiting ror-gamma-t.
SG11202105012VA (en) Aromatic ring-linked dioxino-quinazoline or dioxino-quinoline compounds, compositions and use thereof
IL284764A (en) compounds and their uses
IL287120A (en) Compounds, preparations and methods
IL282765A (en) Compounds suppressing factor, XIa kallikrein, methods of extraction and uses thereof
IL261782A (en) Carbapenem compounds, preparations containing them and their uses